TNYA

MKT CAP:$180M

Tenaya Therapeutics Inc

Market Cap

$180M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.73-$0.01 (-0.90%)

Jun 5, 2026

52W High $2.1052W Low $0.55

Company Details

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-...

CEO

—

IPO Date

Jul 30, 2021

Website

www.tenayatherapeutics.com

Key Metrics TTM

Revenue

$225.0K

- YoY

Net Income

-$83M

EPS (Diluted)

Free Cash Flow

-$65M

Revenue / Share

$0.00

Gross Margin

-683.6%

Operating Margin

-38159.1%

Net Margin

-36891.1%

FCF Margin

-28725.3%

P/S

799.1x

P/E

Earnings Reports

Q2 2026

Aug 12, 2026

PENDING

Q1 2026

May 6, 2026

$225.0K

FY 2025

Mar 11, 2026

Q4 2025

Mar 11, 2026

Q3 2025

Nov 10, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee